Los Angeles Cancer Network (LACN) — Los Angeles, California

Los Angeles Cancer Network (LACN) is a clinical research site located in Los Angeles, California, United States 90017.

Crixeo Health Trust Score: 64/100 (FAIR). This profile has not yet been claimed by the site owner.

Los Angeles Cancer Network (LACN) has participated in 4 clinical trials with 4 currently active.

Therapeutic areas: Metastatic Castration-Resistant Prostate Cancer, Non-small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC).

Sponsors: Pfizer, Daiichi Sankyo, Inhibrx Biosciences, Inc.

Sponsor Feasibility Report

Trust Score: 64/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Los Angeles Cancer Network (LACN)?

Los Angeles Cancer Network (LACN) has a Crixeo Trust Score of 64/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Los Angeles Cancer Network (LACN) conducted?

Los Angeles Cancer Network (LACN) has 4 clinical trials on record, with 4 currently active. Their work covers Metastatic Castration-Resistant Prostate Cancer, Non-small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC).

Is Los Angeles Cancer Network (LACN) accredited by Crixeo Health?

Los Angeles Cancer Network (LACN) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Los Angeles Cancer Network (LACN)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.